SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-021840
Filing Date
2023-06-20
Accepted
2023-06-20 16:00:15
Documents
13
Period of Report
2023-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46843
  Complete submission text file 0001493152-23-021840.txt   262890

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE evfm-20230620.xsd EX-101.SCH 3191
3 XBRL DEFINITION FILE evfm-20230620_def.xml EX-101.DEF 26186
4 XBRL LABEL FILE evfm-20230620_lab.xml EX-101.LAB 35952
5 XBRL PRESENTATION FILE evfm-20230620_pre.xml EX-101.PRE 24844
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4867
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 231024931
SIC: 2834 Pharmaceutical Preparations